Dozens of hospitals in Texas filed a lawsuit accusing pharmaceutical companies and pharmacy giants of fueling the opioid crisis in the state, Fox 4 reported.
Pharmacy
Keene, N.H.-based Cheshire Medical Center will open its first hospital-based pharmacy later this fall, according to The Keene Sentinel.
Ahead of the bellwether opioid trial set to begin next month, Mallinckrodt is considering various options, including a bankruptcy filing to contain a likely legal payout, Bloomberg reported.
Civica Rx CEO Martin VanTrieste isn't afraid of competition, he says. In fact, he welcomes organizations that want to disrupt the system and reduce drug shortages affecting patient care, according to S&P Global.
Citing increasing drug costs and a shift in consumer demand away from traditional pharmacies, Rutgers University in New Brunswick, N.J., will shut down all three of its on-campus pharmacies later this year, according to the Daily Targum.
Advertisement
Health insurer Cigna introduced a plan Sept. 5 to fully cover the cost of expensive gene therapy treatments for patients.
Several pharma companies, distributors and pharmacies must face a federal court jury next month in response to claims that they conspired to commit "unlawful acts"in the marketing, delivering and selling of opioids, according to Bloomberg.
The pharmaceutical industry is now the most poorly regarded industry in the U.S., claiming last place in Gallup's latest poll that asks American's for their views on 25 industries.
States with more comprehensive prescription drug monitoring programs saw hospital use and opioid prescription rates decline, according to a study published Sept. 3 in Health Affairs.
With drug prices increasing five times the rate of inflation, CVS Health is working to make prescriptions more affordable by continuously removing drugs with hyperinflated prices from its formulary.